nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study
|
Hwang, Wontae |
|
|
6 |
4 |
p. |
artikel |
2 |
Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study
|
Jones, Scott |
|
|
6 |
4 |
p. |
artikel |
3 |
Causes, patterns, and epidemiology of tattoo-associated infections since 1820
|
Yoon, Sunghyun |
|
|
6 |
4 |
p. |
artikel |
4 |
Controlled human infection model of Neisseria lactamica in late pregnancy investigating mother-to-infant transmission in the UK: a single-arm pilot trial
|
Theodosiou, Anastasia A |
|
|
6 |
4 |
p. |
artikel |
5 |
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study
|
|
|
|
6 |
4 |
p. |
artikel |
6 |
Global surge of Legionnaires' disease in 2024: urgent call for heightened awareness and preparedness
|
Pareek, Ashutosh |
|
|
6 |
4 |
p. |
artikel |
7 |
Microbiology of tattoo-associated infections since 1820
|
Kondakala, Sandeep |
|
|
6 |
4 |
p. |
artikel |
8 |
Novel human-type receptor-binding H5N1 virus in live poultry markets, China
|
Wen, Feng |
|
|
6 |
4 |
p. |
artikel |
9 |
Pandemic research: the need for a paradigm shift
|
Wang, Lin-Fa |
|
|
6 |
4 |
p. |
artikel |
10 |
Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
|
Heyman, Gabriel |
|
|
6 |
4 |
p. |
artikel |
11 |
Randomised trials of molecular testing for pneumonia
|
Poole, Stephen |
|
|
6 |
4 |
p. |
artikel |
12 |
Reassessing the role of butyrate-producing bacteria in infection risk
|
Parsanathan, Rajesh |
|
|
6 |
4 |
p. |
artikel |
13 |
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study
|
Hamer, Melinda J |
|
|
6 |
4 |
p. |
artikel |
14 |
Severe conflict-associated wound infections complicated by the discovery of carbapenemase-coproducing Pseudomonas aeruginosa in Ukraine
|
Pallett, Scott J C |
|
|
6 |
4 |
p. |
artikel |
15 |
Silent outbreaks of psittacosis revealed using targeted next-generation sequencing
|
Qin, Tian |
|
|
6 |
4 |
p. |
artikel |
16 |
Socioeconomic status and the risk for colonisation or infection with priority bacterial pathogens: a global evidence map
|
Blackmon, Sarah |
|
|
6 |
4 |
p. |
artikel |
17 |
The changing narrative of CHI studies
|
The Lancet Microbe, |
|
|
6 |
4 |
p. |
artikel |
18 |
Tracking pandemic pathogens from wastewater surveillance in international airports: Klebsiella pneumoniae ST16 coproducing NDM-4 and OXA-181 arriving in South America
|
Sousa-Carmo, Rubens R |
|
|
6 |
4 |
p. |
artikel |
19 |
Uganda launches vaccine trial for Sudan virus disease
|
Adepoju, Paul |
|
|
6 |
4 |
p. |
artikel |
20 |
Using demographics of patients to inform treatment of shigellosis in England
|
Mason, Lewis C E |
|
|
6 |
4 |
p. |
artikel |
21 |
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
|
Deming, Meagan E |
|
|
6 |
4 |
p. |
artikel |
22 |
WHO world malaria report 2024
|
Venkatesan, Priya |
|
|
6 |
4 |
p. |
artikel |